Institution
Duke Cancer Institute
Also known as: Duke University Cancer Institute · DCI
- 75running trials
- 32closed trials
- 1researcher
- 7,814publications (OpenAlex)
Researchers
Running trials
Recruiting
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
Not yet recruiting
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Recruiting
Recruiting
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Recruiting
Recruiting
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Safety of HRX215 in Patients After Minor and Major Liver Resection
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Active, not recruiting
Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Recruiting
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Active, not recruiting
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
Showing 50 of 75.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Colorectal cancer6 recruiting
- Ovarian cancer6 recruiting
- Endometrial cancer5 recruiting
- Metastatic breast cancer5 recruiting
- Triple-negative breast cancer5 recruiting
- Bladder cancer4 recruiting
- Gastric and oesophageal cancer3 recruiting
- Pancreatic cancer3 recruiting
- Childhood cancers2 recruiting
- Head and neck cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Prostate cancer2 recruiting
- Sarcoma2 recruiting
- Testicular cancer2 recruiting
- Brain metastases1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Glioblastoma1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Terminated
Terminated
Completed
Completed
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)
Completed
Terminated
Completed
Completed
Recruiting
Terminated
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Terminated
Completed
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Completed
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE)
Completed
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
Completed
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Completed
Terminated
Completed
Completed
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Completed
Registry name variants (33)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Duke Cancer Institute
Durham, North Carolina 27710
70 trials
Duke Cancer Institute Cary
Cary, North Carolina 27518
3 trials
Duke University Cancer Institute
Durham, North Carolina 27710
3 trials
Duke Cancer Institute (Site 4120)
Durham, North Carolina 27710
2 trials
Duke Cancer Institute (Adults and Pediatrics)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (DCI) - Duke Cancer Center
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Duke Cancer Institute - Sarcoma Research
Durham, North Carolina 27710
1 trial
Duke Cancer Institute - School of Medicine
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0038)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0042)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0096)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0106)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0107)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 0641)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 1005)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 1015)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 1541)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 1911)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 2005)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 3005)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 3015)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 3027)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 4005)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 5015)
Durham, North Carolina 27710
1 trial
Duke Cancer Institute (Site 6049)
Durham, North Carolina 27710
1 trial
Duke Institute of Cancer/ Duke University
Durham, North Carolina 27710
1 trial
NCT02343042Selinexor and Backbone Treatments of Multiple Myeloma Patients
Contact: Cristina Gasparetto, MD
Duke University School of Medicine, Duke Cancer Institute
Durham, North Carolina 27710
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer103 works · 6 trials
- Metastatic breast cancer25 works · 8 trials
- Brain metastases17 works · 4 trials
- Head and neck cancer13 works · 6 trials
- Chronic lymphocytic leukaemia7 works · 1 trial
Institution data: ROR 04vt65461 (CC0-1.0)Updated 15 Nov 2026